This website contains general information about medical conditions and treatments. The information is not advice, and should not be treated as such.

The Guidelines Committee welcomes comments and these can be sent to Dr. Michal Inbar-Feigenberg, chair of the guidelines committee at michal.inbar-feigenberg@sickkids.ca

Table of Contents

Amino Acid- and Organic Acid Metabolism

• Glutaric Aciduria
• Tyrosinemia Type 1 Recommendations
• Methylmalonic aciduria/propionic aciduria
• MMA/PA Supplementation
• Links for PKU Guidelines
  • NIH PKU conference and Agency for healthcare research and quality
    • PKU – Phenylketonuria Scientific Review Conference: State of the Science and Future Research Needs (Day 1), February 22, 2012. Sponsored by: NICHD, the Office of Rare Diseases Research and the Office of Dietary Supplements
    • PKU – Phenylketonuria Scientific Review Conference: State of the Science and Future Research Needs (Day 2), February 23, 2012. Sponsored by: NICHD, the Office of Rare Diseases Research and the Office of Dietary Supplements

 

Carbohydrate Metabolism

• no resources available at this time

 

Lysosomal Storage Disorders

• Pompe Disease Guidelines
• MPS II – Consensus Position Statement
• Niemann Pick C
• Elosulfase alfa in the management of Morquio A Syndrome
• Fabry Disease
  • Enzyme Replacement Treatment Eligibility Form
  • Treatment Guidelines
• Gaucher Disease
  • Ontario Guidelines for Treatment of Gaucher Disease by Enzyme Replacement with Imiglucerase or Velaglucerase, or Substrate Reduction Therapy with Miglustat (Version 9; August 2011)

 

Congenital Disorders of Glycosylation

• International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG)

 

Other

• Hypophophatasia
  • Terms of Reference for the National Canadian HPP Clinical Expert Committee
  • Prescribing Criteria Overview
  • HPP ERT Application Form
  • HPP Neonatal Guidelines
  • HPP Treatment References
  • D-tagatase, Hereditary Fructose Intolerance and Health Canada Approval

 

Evaluation and Endorsement of Existing Guidelines using the AGREE II Tool

• Diagnosis and treatment of tyrosinemia type I
• Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia
• Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I
• Pompe Disease, Summary of Guidelines Review, Dec. 2022
• AGREE-Reporting-Checklist-2016